PT-141 research in Canada investigates the sexual arousal-promoting and melanocortin receptor pharmacology of this cyclic heptapeptide. PT-141 (bremelanotide) is a metabolite of Melanotan II with the C-terminal amide removed, giving it partial selectivity for MC3R and MC4R over MC1R. Unlike Melanotan II, PT-141 does not significantly promote skin tanning because of its reduced MC1R activity. Canadian neuroscience and reproductive biology researchers study PT-141 for its CNS-mediated effects on sexual arousal pathways through hypothalamic and limbic MC4R activation.
MC4R and Sexual Arousal Research
The MC4R receptor in the hypothalamus, particularly in the medial preoptic area (MPOA) and paraventricular nucleus (PVN), plays a critical role in sexual behaviour regulation in animal models. PT-141 activates MC4R in these areas to promote dopamine release in the mesolimbic system and activate pro-sexual neural circuits. Canadian behavioural neuroscience researchers study how MC4R agonism translates to changes in sexual motivation and arousal behaviour in rodent models using PT-141 as a pharmacological probe.
Dopaminergic Research
MC4R activation by PT-141 promotes dopamine release in the nucleus accumbens, linking melanocortin receptor pharmacology to reward circuitry. Canadian neuropharmacology researchers study this MC4R-dopamine connection to understand how peptide hormones regulate motivational and hedonic neural circuits relevant to sexual behaviour biology.
Sourcing PT-141 in Canada
Research-grade PT-141 (bremelanotide) is available from EhBuddy Peptides in Canada. Lab-tested for purity. For laboratory research use only.
PT-141 is a unique research tool in Canada for scientists studying melanocortin receptor pharmacology, sexual neuroscience, and the intersection of hypothalamic peptide signalling with dopaminergic reward biology.
